Mukka Proteins Ltd Sees Technical Momentum Shift Amid Strong Weekly Gains

Technical Trend Shift: From Mildly Bearish to Mildly Bullish

The technical landscape for Mukka Proteins has evolved significantly over the past week. The overall trend has transitioned from mildly bearish to mildly bullish, supported by several key indicators. The Moving Average Convergence Divergence (MACD) on the weekly chart has turned mildly bullish, suggesting increasing upward momentum. However, the monthly MACD remains inconclusive, indicating that longer-term momentum is yet to fully confirm the uptrend.

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no clear signal, hovering in neutral territory. This suggests that the stock is neither overbought nor oversold, providing room for further price movement without immediate risk of reversal due to exhaustion.

Bollinger Bands on the weekly chart are bullish, reflecting price expansion and volatility consistent with upward momentum. Conversely, the monthly Bollinger Bands indicate a sideways trend, highlighting that while short-term momentum is positive, the longer-term price range remains relatively stable.

Moving Averages and Other Indicators

Daily moving averages still show a mildly bearish stance, indicating some short-term resistance or consolidation. This divergence between daily and weekly signals suggests that while the broader trend is improving, short-term traders may face some volatility or pullbacks.

The Know Sure Thing (KST) indicator on the weekly chart is bullish, reinforcing the positive momentum narrative. Dow Theory assessments also align with this view, showing mildly bullish trends on both weekly and monthly scales, which is a positive sign for sustained upward movement.

On-Balance Volume (OBV) analysis reveals a mildly bullish trend on the weekly chart, indicating that volume is supporting price gains. However, the monthly OBV shows no clear trend, suggesting that longer-term accumulation or distribution remains uncertain.

Price Performance and Market Comparison

Mukka Proteins closed at ₹26.37 on 14 Aug 2026, up from the previous close of ₹24.16, with an intraday high of ₹28.10 and low of ₹25.53. The stock remains below its 52-week high of ₹31.20 but comfortably above its 52-week low of ₹18.32, signalling a recovery phase.

Comparing returns with the Sensex reveals Mukka Proteins’ outperformance in recent periods. Over the past week, the stock returned 14.21%, while the Sensex declined by 1.11%. Over one month, Mukka Proteins gained 10.01% against a modest 0.60% rise in the Sensex. Year-to-date, the stock has appreciated 9.83%, contrasting with the Sensex’s 8.38% decline. However, over the last year, Mukka Proteins has declined 5.28%, slightly worse than the Sensex’s 3.05% fall, reflecting some volatility and sector-specific challenges.

Mojo Score Upgrade and Market Capitalisation Context

MarketsMOJO has upgraded Mukka Proteins’ Mojo Grade from Sell to Hold as of 13 Aug 2026, reflecting improved technical and fundamental outlooks. The current Mojo Score stands at 58.0, indicating moderate confidence in the stock’s prospects. The company remains classified as a micro-cap, which typically entails higher volatility and risk but also potential for outsized gains if turnaround efforts succeed.

The upgrade is consistent with the technical signals observed, particularly the weekly MACD and KST bullishness, as well as the positive Dow Theory confirmation. Investors should note that while the daily moving averages remain mildly bearish, the broader weekly and monthly trends suggest a stabilising and potentially improving price environment.

Sector and Industry Positioning

Mukka Proteins operates within the FMCG sector, a space known for steady demand but also intense competition and margin pressures. The company’s recent price momentum and technical improvements may reflect better operational performance or market sentiment shifts favouring micro-cap FMCG stocks. However, the lack of strong monthly RSI or OBV trends indicates that longer-term conviction is still developing.

Investors should weigh these technical improvements against the company’s fundamentals and sector dynamics. The stock’s recent outperformance relative to the Sensex and its own historical lows is encouraging, but the one-year negative return highlights the need for cautious optimism.

Investor Takeaway and Outlook

The technical parameter changes for Mukka Proteins Ltd indicate a cautious but positive shift in momentum. The weekly MACD and KST bullish signals, combined with mildly bullish Dow Theory confirmation, suggest that the stock is emerging from a consolidation or correction phase. The absence of strong RSI or monthly OBV signals advises prudence, as the longer-term trend is not yet decisively bullish.

Price action above ₹26.00 with intraday highs touching ₹28.10 shows renewed buying interest, but the daily moving averages’ mildly bearish stance warns of potential short-term resistance. Investors should monitor whether the stock can sustain above its recent breakout levels and whether monthly indicators begin to confirm the weekly bullishness.

Given the micro-cap status and sector challenges, Mukka Proteins remains a speculative holding with moderate upside potential. The recent Mojo Grade upgrade to Hold reflects this balanced view. Investors seeking exposure to FMCG micro-caps with improving technicals may consider adding the stock with appropriate risk management.

Overall, Mukka Proteins’ technical momentum shift and market outperformance relative to the Sensex over recent weeks mark it as a stock to watch closely in the coming months.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →